Mesotherapy — Skin Hydration and Collagen Support

Mesotherapy at DermaStar delivers nutrient cocktails into the skin's middle layer (the mesoderm) via a series of microinjections, stimulating hydration, collagen production, and cellular regeneration without surgery. The clinic uses premium injectables including Dermaheal HSR — a formula containing 58 active substances (hyaluronic acid, amino acids, peptides, and vitamins) — as well as Neauvia and Redensity I pure HA. Treatments cover the face, neck, and décolletage. Three sessions at 2–4 week intervals are the standard course. Numbing cream is applied before treatment to minimise discomfort.

Mesotherapy — derived from the French term 'mésothérapie' — refers to the technique of delivering bioactive compounds directly into the mesodermal layer of the skin, bypassing the superficial epidermis barrier that prevents topical products from reaching their targets. The principle relies on the pharmacological and mechanical stimulus of micro-injections: each puncture creates a controlled microtrauma that activates skin repair pathways, while the injected cocktail directly supplies the fibroblasts and other dermal cells with substrates for collagen and elastin synthesis. At DermaStar, three product families are used depending on the clinical objective: **Dermaheal HSR** (skin rejuvenation) contains 58 active substances in a single formulation: cross-linked hyaluronic acid for hydration, 14 amino acids as collagen precursors, peptides including GHRP-6 and acetyl hexapeptide-3, a full B-vitamin complex, coenzyme Q10, and minerals. This is a comprehensive treatment for diffuse ageing — fine lines, dull texture, and loss of skin density. It is particularly suitable for patients who want a broadly regenerative outcome rather than a targeted correction. **Neauvia mesotherapy** uses a next-generation HA platform with amino acid co-formulation, designed to biostimulate fibroblasts more aggressively than pure HA products. It is positioned between a pure skin booster and a traditional injectable filler. **Redensity I** (Teoxane) is a pure, non-cross-linked HA product combined with a proprietary blend of amino acids, antioxidants, minerals, and B vitamins. It is available in 1 ml and 3 ml syringes. The 3 ml volume is used for larger treatment areas — full face, neck, and décolletage — where a single session needs to cover substantial surface area. The standard mesotherapy protocol at DermaStar consists of 3 sessions spaced 2–4 weeks apart. Before the session begins, EMLA topical anaesthetic cream is applied for 20–30 minutes. The physician then delivers the chosen product via multiple microinjections using a very fine needle across the treatment zone. Injection sites may show small papules (lumps) for several hours; redness typically clears within 24 hours. Puncture marks are rarely visible beyond the day of treatment. Aftercare: avoid saunas, swimming pools, and intense physical exercise for 24–48 hours post-session. Sunscreen is recommended during any sun exposure in the days following treatment. Patients on blood thinners should expect slightly more bruising. Immune-compromised patients may experience slower resolution of injection marks. Mesotherapy is suitable for a wide age range: younger patients may use it preventatively to maintain skin density; older patients use it alongside injectables or laser treatments as a supportive modality. Results accumulate over the course of treatment and continue to improve for several weeks after the final session.